使HIST1H2BH

Wenxue Zhang1, Xian Chen1, Zhe Wang1

  • 1Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, People's Republic of China.

概括

在多发性骨髓瘤 (MM) 患者中增加HIST1H2BH表达与预后较差相关. 这一发现表明HIST1H2BH是MM进展和向治疗开发的潜在生物标志物.